Trial result ·
Impact of Aortic Annulus Size on Outcomes After Aortic Valve Replacement: The PARTNER 3 Trial.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This is a later analysis of the PARTNER 3 trial. It included low-risk people with severe aortic stenosis and symptoms. They were randomly given a catheter valve or open-heart valve surgery. The catheter valve was the SAPIEN 3. The team asked if aortic annulus size changed 5-year outcomes. 925 people had scans of annulus size.
What they found
The main outcome was death, stroke, or return to hospital. Over 5 years, rates were similar for both treatments. That held for small annuli and for large annuli. Valve failure was similar in both groups. Health status was also similar. Annulus size did not change these results.
What it means for patients
The authors conclude that the catheter valve gave similar 5-year results to surgery. They say this held no matter the annulus size.
Why it is not certain yet
This was a post hoc analysis, done after the main trial. It covers low-risk people only. Splitting by annulus size leaves fewer people in each group. The abstract does not give results beyond 5 years.
The registered trial
The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.
Source
Impact of Aortic Annulus Size on Outcomes After Aortic Valve Replacement: The PARTNER 3 Trial.
PubMed · PMID 42508852We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Stroke publications